Study identity card

ECRAID-PRIME

Belgium France Germany Ireland Poland Spain United Kingdom Georgia
Share
  • Disease: Acute SARS-CoV-2, Avian Influenza, Influenza
  • Study type: Adaptive Platform Trial
  • Study aim: To evaluate new treatments for COVID-19 and COVID-like illnesses within community and primary care settings
  • Number of participants enrolled: 291
  • Study enrolling from

Study Data

  • Adults
  • Primary care
  • Community
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza
  • Pharmacological intervention
  • Nitric Oxide Nasal Spray

Other information

Funders:

  • Horizon 2021

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to